Annual Accounts Payable
$3.49 M
+$150.00 K+4.49%
31 December 2023
Summary:
Aptose Biosciences annual accounts payable is currently $3.49 million, with the most recent change of +$150.00 thousand (+4.49%) on 31 December 2023. During the last 3 years, it has risen by +$1.32 million (+60.85%). APTO annual accounts payable is now at all-time high.APTO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.83 M
-$5.28 M-74.27%
30 September 2024
Summary:
Aptose Biosciences quarterly accounts payable is currently $1.83 million, with the most recent change of -$5.28 million (-74.27%) on 30 September 2024. Over the past year, it has dropped by -$981.00 thousand (-34.90%). APTO quarterly accounts payable is now -74.27% below its all-time high of $7.11 million, reached on 30 June 2024.APTO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.5% | -34.9% |
| 3 y3 years | +60.9% | +12.3% |
| 5 y5 years | +165.6% | +55.9% |
APTO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +105.5% | -74.3% | +60.0% |
| 5 y | 5 years | at high | +165.6% | -74.3% | +60.0% |
| alltime | all time | at high | +2306.6% | -74.3% | +2052.9% |
Aptose Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.83 M(-74.3%) |
| June 2024 | - | $7.11 M(+193.7%) |
| Mar 2024 | - | $2.42 M(-60.0%) |
| Dec 2023 | $3.49 M(+4.5%) | $6.05 M(+115.1%) |
| Sept 2023 | - | $2.81 M(-19.7%) |
| June 2023 | - | $3.50 M(-36.6%) |
| Mar 2023 | - | $5.52 M(-12.8%) |
| Dec 2022 | $3.34 M(+96.7%) | $6.33 M(+161.8%) |
| Sept 2022 | - | $2.42 M(+1.0%) |
| June 2022 | - | $2.39 M(+109.2%) |
| Mar 2022 | - | $1.14 M(-32.7%) |
| Dec 2021 | $1.70 M(-21.7%) | $1.70 M(+4.2%) |
| Sept 2021 | - | $1.63 M(-44.1%) |
| June 2021 | - | $2.91 M(+81.2%) |
| Mar 2021 | - | $1.61 M(-25.9%) |
| Dec 2020 | $2.17 M(+10.8%) | $2.17 M(+42.0%) |
| Sept 2020 | - | $1.53 M(-19.7%) |
| June 2020 | - | $1.90 M(-5.7%) |
| Mar 2020 | - | $2.02 M(+2.9%) |
| Dec 2019 | $1.96 M(+49.0%) | $1.96 M(+67.0%) |
| Sept 2019 | - | $1.17 M(-5.3%) |
| June 2019 | - | $1.24 M(+6.0%) |
| Mar 2019 | - | $1.17 M(-11.0%) |
| Dec 2018 | $1.31 M(+123.3%) | $1.31 M(+123.3%) |
| Dec 2017 | $589.00 K(+167.1%) | $589.00 K(+509.7%) |
| Sept 2016 | - | $96.60 K(+13.6%) |
| June 2016 | - | $85.00 K(-66.6%) |
| Mar 2016 | - | $254.20 K(+150.9%) |
| Sept 2015 | - | $101.30 K(-16.1%) |
| June 2015 | - | $120.80 K(-72.4%) |
| Mar 2015 | - | $437.00 K(+11.1%) |
| Dec 2014 | $220.50 K(-63.1%) | - |
| Sept 2014 | - | $393.30 K(-34.2%) |
| May 2014 | $598.10 K(-13.5%) | $598.10 K(+124.1%) |
| Feb 2014 | - | $266.90 K(+49.1%) |
| Nov 2013 | - | $179.00 K(-71.6%) |
| Aug 2013 | - | $630.80 K(-8.8%) |
| May 2013 | $691.80 K(+121.4%) | $691.80 K(+235.7%) |
| Feb 2013 | - | $206.10 K(-38.0%) |
| Nov 2012 | - | $332.20 K(+91.8%) |
| Aug 2012 | - | $173.20 K(-44.6%) |
| May 2012 | $312.50 K(+42.0%) | $312.50 K(+165.5%) |
| Feb 2012 | - | $117.70 K(-65.9%) |
| Nov 2011 | - | $344.80 K(+99.8%) |
| Aug 2011 | - | $172.60 K(-21.6%) |
| May 2011 | $220.10 K(-40.0%) | $220.10 K(-6.0%) |
| Feb 2011 | - | $234.20 K(-49.3%) |
| Nov 2010 | - | $462.00 K(-33.4%) |
| Aug 2010 | - | $694.10 K(+89.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2010 | $366.80 K(+33.7%) | $366.80 K(-35.1%) |
| Feb 2010 | - | $565.10 K(+52.5%) |
| Nov 2009 | - | $370.60 K(+12.7%) |
| Aug 2009 | - | $328.70 K(+19.8%) |
| May 2009 | $274.30 K(-70.5%) | $274.30 K(+11.6%) |
| Feb 2009 | - | $245.80 K(-24.2%) |
| Nov 2008 | - | $324.10 K(-54.8%) |
| Aug 2008 | - | $716.50 K(-22.8%) |
| May 2008 | $928.30 K(-10.1%) | $928.30 K(-0.1%) |
| Feb 2008 | - | $928.90 K(+140.5%) |
| Nov 2007 | - | $386.30 K(-60.1%) |
| Aug 2007 | - | $967.80 K(-6.2%) |
| May 2007 | $1.03 M(+104.8%) | $1.03 M(+457.9%) |
| Feb 2007 | - | $185.00 K(-63.8%) |
| Nov 2006 | - | $511.20 K(-5.3%) |
| Aug 2006 | - | $539.60 K(+7.1%) |
| May 2006 | $504.00 K(-40.8%) | $504.00 K(-13.6%) |
| Feb 2006 | - | $583.00 K(-69.3%) |
| Nov 2005 | - | $1.90 M(+167.7%) |
| Aug 2005 | - | $709.50 K(-16.7%) |
| May 2005 | $851.80 K(-52.2%) | $851.80 K(-28.7%) |
| Feb 2005 | - | $1.19 M(-15.2%) |
| Nov 2004 | - | $1.41 M(-29.6%) |
| Aug 2004 | - | $2.00 M(+12.1%) |
| May 2004 | $1.78 M(+85.6%) | $1.78 M(-11.0%) |
| Feb 2004 | - | $2.00 M(-26.6%) |
| Nov 2003 | - | $2.73 M(+25.8%) |
| Aug 2003 | - | $2.17 M(+125.9%) |
| May 2003 | $960.40 K(+232.1%) | $960.40 K(+88.1%) |
| Feb 2003 | - | $510.50 K(-46.1%) |
| Nov 2002 | - | $946.90 K(+112.3%) |
| Aug 2002 | - | $446.10 K(+54.3%) |
| May 2002 | $289.20 K(-85.8%) | $289.20 K(-55.5%) |
| Feb 2002 | - | $649.80 K(+9.6%) |
| Nov 2001 | - | $593.00 K(-64.6%) |
| Aug 2001 | - | $1.68 M(-17.6%) |
| May 2001 | $2.03 M(+42.4%) | $2.03 M(+343.9%) |
| Feb 2001 | - | $458.20 K(-62.1%) |
| Nov 2000 | - | $1.21 M(+68.8%) |
| Aug 2000 | - | $715.60 K(-49.9%) |
| May 2000 | $1.43 M(+62.0%) | $1.43 M(+59.4%) |
| Feb 2000 | - | $895.90 K(-51.1%) |
| Nov 1999 | - | $1.83 M(+82.7%) |
| Aug 1999 | - | $1.00 M(+13.8%) |
| May 1999 | $881.70 K(+507.6%) | $881.70 K(+79.3%) |
| Feb 1998 | - | $491.80 K(-41.7%) |
| Nov 1997 | - | $843.30 K(+67.3%) |
| Aug 1997 | - | $504.00 K |
| May 1997 | $145.10 K | - |
FAQ
- What is Aptose Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Aptose Biosciences?
- What is Aptose Biosciences annual accounts payable year-on-year change?
- What is Aptose Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aptose Biosciences?
- What is Aptose Biosciences quarterly accounts payable year-on-year change?
What is Aptose Biosciences annual accounts payable?
The current annual accounts payable of APTO is $3.49 M
What is the all time high annual accounts payable for Aptose Biosciences?
Aptose Biosciences all-time high annual accounts payable is $3.49 M
What is Aptose Biosciences annual accounts payable year-on-year change?
Over the past year, APTO annual accounts payable has changed by +$150.00 K (+4.49%)
What is Aptose Biosciences quarterly accounts payable?
The current quarterly accounts payable of APTO is $1.83 M
What is the all time high quarterly accounts payable for Aptose Biosciences?
Aptose Biosciences all-time high quarterly accounts payable is $7.11 M
What is Aptose Biosciences quarterly accounts payable year-on-year change?
Over the past year, APTO quarterly accounts payable has changed by -$981.00 K (-34.90%)